Marker Therapeutics News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

08.01.24	Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization (Benzinga)
09.08.23	Pre-market Movers: TYGO, BRSH, TNGX, VERI, DOCS… (RTTNews)
22.11.22	Marker Therapeutics Announces FDA's Clearance Of IND For MT-601 (RTTNews)
20.01.22	Pre-market Movers: STRR, BXRX, CALA, VALN, TKLF… (RTTNews)
20.08.21	Pre-market Movers: GOVX, PROG, SONN, MRIN, NVIV… (RTTNews)
19.08.21	Marker Therapeutics Awarded $13.1 Million Grant from the Cancer Prevention and Research Institute of Texas (PR Newswire)
10.08.21	Marker Therapeutics Reports Second Quarter 2021 Operating and Financial Results (PR Newswire)
28.07.21	Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility (PR Newswire)
06.07.21	Marker Therapeutics Announces Completion of Safety Lead-In Portion of Phase 2 Study in Post-Transplant AML (PR Newswire)
16.06.21	Marker Therapeutics to Present at the Virtual Raymond James Human Health Innovation Conference (PR Newswire)
31.03.21	Analysten sehen für Marker Therapeutics-Aktie Luft nach oben (finanzen.net)
06.01.21	MRKR Soars As FDA Lifts Hold On MT-401, RYTM Sells Priority Review Voucher, MLND Dumps MLE-301 (RTTNews)
05.01.21	Marker Therapeutics Says FDA Lifts Partial Clinical Hold On Phase 2 AML Trial Of MT-401 (RTTNews)
11.02.20	Stock Alert: Marker Therapeutics (MRKR) (RTTNews)
22.07.19	FDA Says No To BHVN, Detraxi Eyeing Solution For Blood Shortage, MRKR On Watch (RTTNews)
04.01.19	BTAI Up 105% In 5 Days, NVAX Gets A Shot In The Arm, BMY Snaps Up CELG (RTTNews)
06.11.18	CLSD Loses Shine, AVDL's Q3 Results Disappoint, CWBR Briefly Suspends NASH Trial (RTTNews)
30.10.18	CASI Turning Heads, GEN On Watch, MRKR For The Long Haul (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V